Skip to content
Review Open access

Clinicopathological Profile of Lung Cancer Patients

Jul 2026 · Journal of Nobel Medical College · 0 citations · 14 references

TL;DR

Lung cancer patients attending Nobel Medical College Teaching Hospital predominantly presented at advanced stages, and adenocarcinoma was the leading histological subtype.

Abstract

Background: Lung cancer is a common malignancy and an important cause of cancer-related mortality. Institutional data from Eastern Nepal are limited. Materials and Methods: A descriptive hospital-based cross-sectional study was conducted in the Clinical Oncology Department of Nobel Medical College Teaching Hospital, Biratnagar, Nepal. Records of 50 confirmed lung cancer patients registered from January 2023 to December 2023 were reviewed. Data were retrieved from the oncology registry and hospital medical records and analyzed using descriptive statistics. Results: The mean age was 63.6 ± 11.3 years, with a median age of 68 years (range 27-79 years). Males and females were equally represented (25 each, 50.0%). Stage IV disease was observed in 30 (60.0%) patients and Stage III disease in 20 (40.0%) patients. Adenocarcinoma was the most common histological subtype (22, 44.0%), followed by squamous cell carcinoma (16, 32.0%) and small cell carcinoma (4, 8.0%). Smoking history was present in 35 (70.0%) patients. Conclusion: Lung cancer patients attending Nobel Medical College Teaching Hospital predominantly presented at advanced stages, and adenocarcinoma was the leading histological subtype.  

Read PDF

Similar papers

Review Mar 2026

The correlation between clinical and pathological features of renal cancer patients with survival after surgical intervention

Findings highlight the importance of considering clinical and pathological features in the management and prognosis of RCC patients and highlight the importance of considering clinical and pathological features in the management and prognosis of patients diagnosed with malignant renal tumors.

Mohammad Sadri, S. Masudi, S. Farshid et al. · 0 citations
Open access Aug 2026

Treatment and outcomes of people with bladder cancer in Armenia: a retrospective hospital-based study

It is shown that the survival of patients with metastatic BC in Armenia is poor, with an mOS just surpassing 1 year, and it is believed that the implementation of newer drugs, like immunotherapy and antibody-drug conjugates, may improve outcomes.

Samvel Bardakhchyan, S. Karamyan, Hovsep Gharadaghyan et al. · 0 citations
Open access Jul 2026

Clinicopathological Spectrum, Molecular Subtypes, and Contemporary Treatment Patterns of Breast Cancer in Bangladesh

Longer symptom duration was associated with larger tumor size, and larger tumor size was significantly associated with nodal positivity, highlighting the importance of early diagnosis, timely referral, and breast cancer awareness programs to improve clinical outcomes.

Ovi Mra, MZ Rahman, MF Eastiak et al. · 0 citations
Open access Jul 2026

Clinical Features and Etiology of Patients Having Advanced Stage Hepatocellular Carcinoma on Initial Presentation

Chronic viral hepatitis, especially HCV infection, was the primary risk factor in this group of patients for advanced-stage HCC, which is an indication of the need for better surveillance, early hepatopathy screening, and timely intervention measures to minimize late-stage presentation and hepatopathy-related mortality...

Nawal Qadus, Fahad Naim, Noorainezhad Maryam et al. · 0 citations
Open access Aug 2026

Cancer Distribution in an Oncology Outpatient Clinic in Eastern Türkiye: A 1-Year Retrospective Study

Female patients predominated slightly, and the incidence of gastric and esophageal cancers was significantly higher than reported in the literature, suggesting that regional environmental, dietary, and sociocultural factors play a critical role in shaping cancer distribution across the Eastern Anatolia region.

Ismet Kızılkaya, A. Ozkahraman · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.